Interim data monitoring to enroll higher-risk participants in hiv prevention trials

Simple item page
dc.contributor.authorHalpern, V.
dc.contributor.authorObunge, O.
dc.contributor.authorOgunsola, F.T.
dc.contributor.authorOtunsanya, S.
dc.contributor.authorUmo-tong, J.
dc.contributor.authorWang, C.
dc.contributor.authorMehta, N.
dc.date.accessioned2020-01-06T12:31:15Z
dc.date.available2020-01-06T12:31:15Z
dc.date.issued2009-06-23
dc.descriptionStaff publicationsen_US
dc.description.abstractBackground: Lower-than-expected incidence of HIV undermines sample size calculations and compromises the power of a HIV prevention trial. We evaluated the effectiveness of interim monitoring of HIV infection rates and on-going modification of recruitment strategies to enroll women at higher risk of HIV in the Cellulose Sulfate Phase III study in Nigeria. Methods: We analyzed prevalence and incidence of HIV and other sexually transmitted infections, demographic and sexual behavior characteristics aggregated over the treatment groups on a quarterly basis. The site investigators were advised on their recruitment strategies based on the findings of the interim analyses. Results: A total of 3619 women were screened and 1644 enrolled at the Ikeja and Apapa clinics in Lagos, and at the Central and Peripheral clinics in Port Harcourt. Twelve months after study initiation, the overall incidence of HIV was less than one-third of the pre-study assumption, with rates of HIV that varied substantially between clinics. Due to the low prevalence and incidence rates of HIV, it was decided to close the Ikeja clinic in Lagos and to find new catchment areas in Port Harcourt. This strategy was associated with an almost two-fold increase in observed HIV incidence during the second year of the study. Conclusion: Given the difficulties in estimating HIV incidence, a close monitoring of HIV prevalence and incidence rates during a trial is warranted. The on-going modification of recruitment strategies based on the regular analysis of HIV rates appeared to be an efficient method for targeting populations at greatest risk of HIV infection and increasing study power in the Nigeria trial. Trial Registration: The trial was registered with the ClinicalTrials.gov registry under #NCT00120770 http://clinicaltrials.gov/ct2/show/NCT00120770en_US
dc.identifier.citationHalpern, V., Obunge, O., Ogunsola, F., Otusanya, S., Umo-Otong, J., Wang, C. and Mehta, N. (2009). Interim data monitoring to enroll higher-risk participants in HIV prevention trials. BMC Medical Research Methodology, 9: 44-46.en_US
dc.identifier.urihttps://www.google.com/search?q=Interim+data+monitoring+to+enroll+higher-risk+participants+in+HIV+prevention+trials&oq=Interim+data+monitoring+to+enroll+higher-risk+participants+in+HIV+prevention+trials&aqs=chrome..69i57j69i60.674j0j7&sourceid=chrome&ie=UTF-8
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/7258
dc.language.isoenen_US
dc.relation.ispartofseriesBMC Medical Research Methodology;Vol.9
dc.subjectHIV preventionen_US
dc.subjectCellulose Sulfate Phase III studyen_US
dc.subjectWomenen_US
dc.subjectNigeriaen_US
dc.subjectResearch Subject Categories::MEDICINE::Microbiology, immunology, infectious diseasesen_US
dc.titleInterim data monitoring to enroll higher-risk participants in hiv prevention trialsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Interim data monitoring to enroll higher-risk participants in HIV prevention trials.pdf
Size:
210.18 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical Microbiology and parasitology- Scholarly Publications